Jiao Wang

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I

Kathleen N. Moore, Amit M. Oza, Nicoletta Colombo et al. · Annals of Oncology · 2021 · 265 citations · Full text

Trilobatin Protects Against Aβ25–35-Induced Hippocampal HT22 Cells Apoptosis Through Mediating ROS/p38/Caspase 3-Dependent Pathway

Nana Chen, Jiao Wang, Yuqi He et al. · Frontiers in Pharmacology · 2020 · 45 citations · Full text

FORWARD I (GOG 3011): A phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)

Kathleen N. Moore, Amit M. Oza, Nicoletta Colombo et al. · Annals of Oncology · 2019 · 44 citations · Full text

Medicine, Folate Receptor Alpha, Pathology +9

Identification and functional analyses of disease-associated P4-ATPase phospholipid flippase variants in red blood cells

Angela Liou, Laurie L. Molday, Jiao Wang et al. · Journal of Biological Chemistry · 2019 · 33 citations · Full text

Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer

Jiao Wang, Fei Zheng, Dandan Wang et al. · Cell Death and Disease · 2024 · 29 citations · Full text